Pantheon Intl PLC - Transaction in Own Shares

1 September 2022

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

Pantheon International Plc
("PIP" or the "Company")

Transaction in own shares

PIP announces that on 1 September 2022, it bought back 500,000 Ordinary Shares of 6.7p (the "Ordinary Shares") at a price of £2.699375 per Ordinary share. The Ordinary shares bought back will be cancelled.

As a result of the above transaction there are 533,923,457 Ordinary shares in issue, none of which are held in treasury, and the Total Voting Rights of the Company are 533,923,457. A buyback of Ordinary Shares by the Company on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the Exchange.

Enquiries:

Helen Steers or Vicki Bradley

Pantheon Ventures (UK) LLP

020 3356 1800

Company Secretary

Link Alternative Fund Administrators Limited

01392 477 500

LEI: 2138001B3CE5S5PEE928

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END